Skip to main content
PMC home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1996 May 15;24(10):1901–1907. doi: 10.1093/nar/24.10.1901

Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.

S P Ho 1, D H Britton 1, B A Stone 1, D L Behrens 1, L M Leffet 1, F W Hobbs 1, J A Miller 1, G L Trainor 1
PMCID: PMC145867  PMID: 8657572

Abstract

Antisense oligonucleotides can vary significantly and unpredictably in their ability to inhibit protein synthesis. Libraries of chimeric oligonucleotides and RNase H were used to cleave and thereby locate sites on human multidrug resistance-1 RNA transcripts that are relatively accessible to oligonucleotide hybridization. In cell culture, antisense sequences designed to target these sites were significantly more active than oligonucleotides selected at random. This methodology should be generally useful for identification of potent antisense sequences. Correlation between oligonucleotide activity in the cell culture assay and in an in vitro RNase H assay supports the proposed role of the enzyme in the mechanism of antisense suppression in the cell.

Full Text

The Full Text of this article is available as a PDF (126.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chiang M. Y., Chan H., Zounes M. A., Freier S. M., Lima W. F., Bennett C. F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem. 1991 Sep 25;266(27):18162–18171. [PubMed] [Google Scholar]
  2. Efferth T., Löhrke H., Volm M. Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res. 1989 Nov-Dec;9(6):1633–1637. [PubMed] [Google Scholar]
  3. Ehresmann C., Baudin F., Mougel M., Romby P., Ebel J. P., Ehresmann B. Probing the structure of RNAs in solution. Nucleic Acids Res. 1987 Nov 25;15(22):9109–9128. doi: 10.1093/nar/15.22.9109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Han H., Schepartz A., Pellegrini M., Dervan P. B. Mapping RNA regions in eukaryotic ribosomes that are accessible to methidiumpropyl-EDTA.Fe(II) and EDTA.Fe(II). Biochemistry. 1994 Aug 23;33(33):9831–9844. doi: 10.1021/bi00199a004. [DOI] [PubMed] [Google Scholar]
  5. Hayase Y., Inoue H., Ohtsuka E. Secondary structure in formylmethionine tRNA influences the site-directed cleavage of ribonuclease H using chimeric 2'-O-methyl oligodeoxyribonucleotides. Biochemistry. 1990 Sep 18;29(37):8793–8797. doi: 10.1021/bi00489a041. [DOI] [PubMed] [Google Scholar]
  6. Inoue H., Hayase Y., Iwai S., Ohtsuka E. Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Lett. 1987 May 11;215(2):327–330. doi: 10.1016/0014-5793(87)80171-0. [DOI] [PubMed] [Google Scholar]
  7. Jaroszewski J. W., Kaplan O., Syi J. L., Sehested M., Faustino P. J., Cohen J. S. Concerning antisense inhibition of the multiple drug resistance gene. Cancer Commun. 1990;2(8):287–294. doi: 10.3727/095535490820874254. [DOI] [PubMed] [Google Scholar]
  8. Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987 Oct 26;15(20):8125–8148. doi: 10.1093/nar/15.20.8125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Laptev A. V., Lu Z., Colige A., Prockop D. J. Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA. Biochemistry. 1994 Sep 13;33(36):11033–11039. doi: 10.1021/bi00202a024. [DOI] [PubMed] [Google Scholar]
  10. Latham J. A., Cech T. R. Defining the inside and outside of a catalytic RNA molecule. Science. 1989 Jul 21;245(4915):276–282. doi: 10.1126/science.2501870. [DOI] [PubMed] [Google Scholar]
  11. Ma W. P., Hamilton S. E., Stowell J. G., Byrn S. R., Davisson V. J. Sequence specific cleavage of messenger RNA by a modified ribonuclease H. Bioorg Med Chem. 1994 Mar;2(3):169–179. doi: 10.1016/s0968-0896(00)82012-x. [DOI] [PubMed] [Google Scholar]
  12. Monia B. P., Lesnik E. A., Gonzalez C., Lima W. F., McGee D., Guinosso C. J., Kawasaki A. M., Cook P. D., Freier S. M. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem. 1993 Jul 5;268(19):14514–14522. [PubMed] [Google Scholar]
  13. Morvan F., Porumb H., Degols G., Lefebvre I., Pompon A., Sproat B. S., Rayner B., Malvy C., Lebleu B., Imbach J. L. Comparative evaluation of seven oligonucleotide analogues as potential antisense agents. J Med Chem. 1993 Jan 22;36(2):280–287. doi: 10.1021/jm00054a013. [DOI] [PubMed] [Google Scholar]
  14. Peyman A., Helsberg M., Kretzschmar G., Mag M., Grabley S., Uhlmann E. Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1. Biol Chem Hoppe Seyler. 1995 Mar;376(3):195–198. doi: 10.1515/bchm3.1995.376.3.195. [DOI] [PubMed] [Google Scholar]
  15. Richert N. D., Aldwin L., Nitecki D., Gottesman M. M., Pastan I. Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells. Biochemistry. 1988 Oct 4;27(20):7607–7613. doi: 10.1021/bi00420a006. [DOI] [PubMed] [Google Scholar]
  16. Roller E., Klumpp B., Krause J., Eichelbaum M., Schumacher K. Influence of sequential exposure to R-verapamil or B8509-035 on rhodamine 123 accumulation in human lymphoblastoid cell lines. Cancer Chemother Pharmacol. 1993;32(2):151–155. doi: 10.1007/BF00685619. [DOI] [PubMed] [Google Scholar]
  17. Stull R. A., Taylor L. A., Szoka F. C., Jr Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices. Nucleic Acids Res. 1992 Jul 11;20(13):3501–3508. doi: 10.1093/nar/20.13.3501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Uchiyama Y., Miura Y., Inoue H., Ohtsuka E., Ueno Y., Ikehara M., Iwai S. Studies of the interactions between Escherichia coli ribonuclease HI and its substrate. J Mol Biol. 1994 Nov 4;243(4):782–791. doi: 10.1016/0022-2836(94)90047-7. [DOI] [PubMed] [Google Scholar]
  19. Ueda K., Clark D. P., Chen C. J., Roninson I. B., Gottesman M. M., Pastan I. The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem. 1987 Jan 15;262(2):505–508. [PubMed] [Google Scholar]
  20. Wagner R. W. Gene inhibition using antisense oligodeoxynucleotides. Nature. 1994 Nov 24;372(6504):333–335. doi: 10.1038/372333a0. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES